データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (Sac-TMT) at 2024 CSCO Congress
Malaysia's Forest City Incentives Could Benefit Property Market -- Market Talk
Singapore REITs to Gain From Further Fed Rate Cuts -- Market Talk
Malaysia's Real-Estate Sector Should Benefit From Fed Easing Cycle -- Market Talk
Novel Computational Pathology-based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients With Non-small Cell Lung Cancer in TROPION-Lung01 Phase III Trial
MIDF Positive on REITs' Earnings Prospects for 2H2024 Amid Bright Retail, Industrial Outlook
データなし
データなし